Sun Yat-sen University Cancer Center

Site:	Sun Yat-sen University Cancer Center
Address:
City:	Guangzhou
State:	Guandong
Zip:	510000
Country:	China

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075
1	A Study of NB003 in Patients With Advanced Malignancies	Recruiting	Not yet activated	NB003	NCT04936178